2,544 reports of this reaction
3.2% of all ESTRADIOL GEL 0.1% reports
#4 most reported adverse reaction
HEADACHE is the #4 most commonly reported adverse reaction for ESTRADIOL GEL 0.1%, manufactured by ANI Pharmaceuticals, Inc.. There are 2,544 FDA adverse event reports linking ESTRADIOL GEL 0.1% to HEADACHE. This represents approximately 3.2% of all 79,046 adverse event reports for this drug.
Patients taking ESTRADIOL GEL 0.1% who experience headache should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HEADACHE is moderately reported among ESTRADIOL GEL 0.1% users, representing a notable but not dominant share of adverse events.
In addition to headache, the following adverse reactions have been reported for ESTRADIOL GEL 0.1%:
The following drugs have also been linked to headache in FDA adverse event reports:
HEADACHE has been reported as an adverse event in 2,544 FDA reports for ESTRADIOL GEL 0.1%. This does not prove causation, but indicates an association observed in post-market surveillance data.
HEADACHE accounts for approximately 3.2% of all adverse event reports for ESTRADIOL GEL 0.1%, making it a notable side effect.
If you experience headache while taking ESTRADIOL GEL 0.1%, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.